Brainsway Stock Buy Hold or Sell Recommendation

BRSYF Stock  USD 2.47  0.62  33.51%   
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding BrainsWay is 'Strong Sell'. Macroaxis provides BrainsWay buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BRSYF positions. The advice algorithm takes into account all of BrainsWay's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting BrainsWay's buy or sell advice are summarized below:
Real Value
1.94
Hype Value
2.47
Market Value
2.47
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell BrainsWay given historical horizon and risk tolerance towards BrainsWay. When Macroaxis issues a 'buy' or 'sell' recommendation for BrainsWay, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out BrainsWay Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more detail on how to invest in BrainsWay Pink Sheet please use our How to Invest in BrainsWay guide.
In addition, we conduct extensive research on individual companies such as BrainsWay and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards BrainsWay. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

Execute BrainsWay Buy or Sell Advice

The BrainsWay recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BrainsWay. Macroaxis does not own or have any residual interests in BrainsWay or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BrainsWay's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell BrainsWayBuy BrainsWay
Strong Sell

Market Performance

OKDetails

Volatility

Very riskyDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Moves completely opposite to the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon BrainsWay has a Mean Deviation of 1.0, Standard Deviation of 4.14 and Variance of 17.16
We provide trade advice to complement the prevailing expert consensus on BrainsWay. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure BrainsWay is not overpriced, please confirm all BrainsWay fundamentals, including its cash and equivalents, beta, and the relationship between the price to sales and book value per share . Please also double-check BrainsWay price to earning to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

BrainsWay Trading Alerts and Improvement Suggestions

BrainsWay had very high historical volatility over the last 90 days
The company reported the revenue of 29.66 M. Net Loss for the year was (6.46 M) with profit before overhead, payroll, taxes, and interest of 24.35 M.
About 20.0% of the company shares are held by company insiders

BrainsWay Returns Distribution Density

The distribution of BrainsWay's historical returns is an attempt to chart the uncertainty of BrainsWay's future price movements. The chart of the probability distribution of BrainsWay daily returns describes the distribution of returns around its average expected value. We use BrainsWay price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BrainsWay returns is essential to provide solid investment advice for BrainsWay.
Mean Return
0.47
Value At Risk
0.00
Potential Upside
0.00
Standard Deviation
4.14
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BrainsWay historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

BrainsWay Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BrainsWay or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BrainsWay's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BrainsWay pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
0.57
β
Beta against NYSE Composite-2.08
σ
Overall volatility
4.27
Ir
Information ratio 0.1

BrainsWay Volatility Alert

BrainsWay exhibits very low volatility with skewness of 8.04 and kurtosis of 65.16. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BrainsWay's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BrainsWay's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

BrainsWay Fundamentals Vs Peers

Comparing BrainsWay's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BrainsWay's direct or indirect competition across all of the common fundamentals between BrainsWay and the related equities. This way, we can detect undervalued stocks with similar characteristics as BrainsWay or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of BrainsWay's fundamental indicators could also be used in its relative valuation, which is a method of valuing BrainsWay by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare BrainsWay to competition
FundamentalsBrainsWayPeer Average
Return On Equity-0.2-0.31
Return On Asset-0.0751-0.14
Profit Margin(0.37) %(1.27) %
Operating Margin(0.29) %(5.51) %
Current Valuation(24.98 M)16.62 B
Shares Outstanding33.08 M571.82 M
Shares Owned By Insiders19.83 %10.09 %
Shares Owned By Institutions1.11 %39.21 %
Price To Earning(23.91) X28.72 X
Price To Book0.61 X9.51 X
Price To Sales1.11 X11.42 X
Revenue29.66 M9.43 B
Gross Profit24.35 M27.38 B
EBITDA(3.31 M)3.9 B
Net Income(6.46 M)570.98 M
Cash And Equivalents52.45 M2.7 B
Cash Per Share1.50 X5.01 X
Total Debt754 K5.32 B
Debt To Equity0.01 %48.70 %
Current Ratio7.71 X2.16 X
Book Value Per Share1.46 X1.93 K
Cash Flow From Operations884 K971.22 M
Earnings Per Share(0.22) X3.12 X
Target Price10.75
Number Of Employees11818.84 K
Beta0.2-0.15
Market Capitalization35.72 M19.03 B
Total Asset75.73 M29.47 B
Retained Earnings(47 M)9.33 B
Working Capital10 M1.48 B
Current Asset14 M9.34 B
Current Liabilities4 M7.9 B
Z Score28.28.72

BrainsWay Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BrainsWay . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About BrainsWay Buy or Sell Advice

When is the right time to buy or sell BrainsWay? Buying financial instruments such as BrainsWay Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having BrainsWay in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Emerging Markets ETFs Thematic Idea Now

Emerging Markets ETFs
Emerging Markets ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Emerging Markets ETFs theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether BrainsWay offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BrainsWay's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock:
Check out BrainsWay Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more detail on how to invest in BrainsWay Pink Sheet please use our How to Invest in BrainsWay guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for BrainsWay Pink Sheet analysis

When running BrainsWay's price analysis, check to measure BrainsWay's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrainsWay is operating at the current time. Most of BrainsWay's value examination focuses on studying past and present price action to predict the probability of BrainsWay's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrainsWay's price. Additionally, you may evaluate how the addition of BrainsWay to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Please note, there is a significant difference between BrainsWay's value and its price as these two are different measures arrived at by different means. Investors typically determine if BrainsWay is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BrainsWay's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.